Drug points: Cyclosporin neurotoxicity after chemotherapy
- 24 April 1999
- Vol. 318 (7191) , 1113
- https://doi.org/10.1136/bmj.318.7191.1113
Abstract
Cyclosporin neurotoxicity may result from interaction with chemotherapy used for transplant conditioning 1 2 and to reverse multidrug resistance.3 We describe a case of neurotoxicity after chemotherapy for post-transplantation lymphoproliferative disease. A 9 year old boy presented with monoclonal post-transplantation lymphoproliferative disease six years after cardiac transplantation for congenital heart disease. He was taking azathioprine and cyclosporin (Neoral) 90 mg twice daily (6 mg/kg/day) with whole blood trough concentrations between 29 μg/l and 288 μg/l (Behring enzymatic assay) in the six months before diagnosis. Azathioprine treatment was discontinued, cyclosporin …Keywords
This publication has 5 references indexed in Scilit:
- Cyclosporin a used to reverse drug resistance increases vincristine neurotoxicityAmerican Journal of Hematology, 1992
- Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.1991
- CYCLOSPORINE-ASSOCIATED SEIZURES IN BONE MARROW TRANSPLANT RECIPIENTS GIVEN BUSULFAN AND CYCLOPHOSPHAMIDE PREPARATIVE THERAPYTransplantation, 1991
- MECHANISMS OF CYCLOPHOSPHAMIDE ACTION ON HEPATIC P-450 EXPRESSION1990
- Convulsions associated with cyclosporin A.BMJ, 1985